Understanding and Preventing Aortic Aneurysms in Women
Targeting Endothelial Cell Mineralocorticoid Receptor Against Aortic Aneurysm in Females
This research looks into why abdominal aortic aneurysms are more aggressive in women and explores new ways to prevent them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11052611 on NIH RePORTER |
What this research studies
Abdominal aortic aneurysms (AAA) are a serious condition where the main artery in the belly bulges, and currently, there are no medications to treat it. While women tend to develop AAA later than men, their aneurysms grow faster and are more likely to rupture, leading to worse outcomes. This project aims to understand why women are more vulnerable to severe AAA, especially after menopause or with smoking. Researchers are focusing on a specific pathway involving a protein called the mineralocorticoid receptor in blood vessel cells, which seems to play a role in how AAA develops in females. By understanding these differences, we hope to find new ways to protect women from this life-threatening condition.
Who could benefit from this research
Good fit: This foundational research is focused on understanding the disease mechanisms in women, particularly those who are post-menopausal or smoke, and does not currently involve direct patient participation.
Not a fit: Patients seeking immediate treatment options for existing abdominal aortic aneurysms may not directly benefit from this early-stage mechanistic research.
Why it matters
Potential benefit: If successful, this research could lead to the first medications specifically designed to prevent or slow the progression of abdominal aortic aneurysms in women.
How similar studies have performed: While the role of estrogen in AAA has been controversial, this project explores a novel pathway involving the mineralocorticoid receptor, which has shown promising initial findings in animal models.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Guo, Zhenheng — University of Kentucky
- Study coordinator: Guo, Zhenheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.